15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with leukotriene b4 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miller, C; Yamaguchi, RY; Ziboh, VA | 1 |
Hung, ND; Kim, MR; Sok, DE | 1 |
2 other study(ies) available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and leukotriene b4
Article | Year |
---|---|
Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Docosahexaenoic Acids; Eicosapentaenoic Acid; Epidermis; Fatty Acids, Unsaturated; Fish Oils; Guinea Pigs; Leukotriene B4; Lipoxygenase Inhibitors; Male; Psoriasis; Tumor Cells, Cultured | 1989 |
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosapentaenoic Acid; In Vitro Techniques; Inflammation Mediators; Injections, Intraperitoneal; Leukocytes; Leukotriene B4; Leukotriene C4; Lysophosphatidylcholines; Male; Mice; Mice, Inbred ICR; Oligopeptides; Oxidation-Reduction; Peritonitis; Structure-Activity Relationship; Zymosan | 2011 |